325 related articles for article (PubMed ID: 29760288)
1. [Neuropathologic Subtypes of Frontotemporal Lobar Degeneration].
Tada M; Kakita A
Brain Nerve; 2018 May; 70(5):501-516. PubMed ID: 29760288
[TBL] [Abstract][Full Text] [Related]
2. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
Irwin DJ; Cairns NJ; Grossman M; McMillan CT; Lee EB; Van Deerlin VM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Apr; 129(4):469-91. PubMed ID: 25549971
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological correlations in behavioural variant frontotemporal dementia.
Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal lobar degeneration: diversity of FTLD lesions.
Seilhean D; Bielle F; Plu I; Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
[TBL] [Abstract][Full Text] [Related]
5. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Mann DMA; Snowden JS
Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
[TBL] [Abstract][Full Text] [Related]
6. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
7. Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration.
Hortobágyi T; Cairns NJ
Handb Clin Neurol; 2017; 145():369-381. PubMed ID: 28987183
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
[TBL] [Abstract][Full Text] [Related]
9. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
[TBL] [Abstract][Full Text] [Related]
10. [Progressive nonfluent aphasia].
Murayama S; Saito Y
Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
[TBL] [Abstract][Full Text] [Related]
11. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
[TBL] [Abstract][Full Text] [Related]
12. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE; Matthews BR
CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
[TBL] [Abstract][Full Text] [Related]
13. [Pathomechanisms and clinical aspects of frontotemporal lobar degeneration].
Bürger K; Arzberger T; Stephan J; Levin J; Edbauer D
Nervenarzt; 2017 Feb; 88(2):163-172. PubMed ID: 27999880
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
15. Genetics of FTLD: overview and what else we can expect from genetic studies.
Pottier C; Ravenscroft TA; Sanchez-Contreras M; Rademakers R
J Neurochem; 2016 Aug; 138 Suppl 1():32-53. PubMed ID: 27009575
[TBL] [Abstract][Full Text] [Related]
16. [The molecular pathology of frontotemporal lobar degeneration].
Fujishiro H; Hasegawa M; Arai T
Seishin Shinkeigaku Zasshi; 2010; 112(4):313-24. PubMed ID: 20496755
[TBL] [Abstract][Full Text] [Related]
17. Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
Forrest SL; Crockford DR; Sizemova A; McCann H; Shepherd CE; McGeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; McGinley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM
Neurology; 2019 May; 92(21):e2472-e2482. PubMed ID: 31019099
[TBL] [Abstract][Full Text] [Related]
18. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.
Rabinovici GD; Miller BL
CNS Drugs; 2010 May; 24(5):375-98. PubMed ID: 20369906
[TBL] [Abstract][Full Text] [Related]
19. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
[TBL] [Abstract][Full Text] [Related]
20. Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease.
Takeda T; Seilhean D; Le Ber I; Millecamps S; Sazdovitch V; Kitagawa K; Uchihara T; Duyckaerts C
J Neuropathol Exp Neurol; 2017 Sep; 76(9):800-812. PubMed ID: 28859337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
